Health officials and law enforcement agencies across the country are raising alarms about an emerging synthetic opioid that ...
The law would require Medicare Part D plans to include lower‑cost generics when they are cheaper than brand‑name drugs.
MSN Laboratories launches Semabest, a cost-effective semaglutide generic, enhancing access to diabetes treatment in India.
The Food and Drug Administration has announced a voluntary recall of select lots of Xanax. The incredibly popular ...
The good news is that Congress does not need to start from scratch when addressing drug prices. But it does need to act now.
The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price ...
Lawmakers are attempting to make “generic means cheaper” actually mean something agai ..
The Iran conflict is set to cause a significant price hike of 30-40% for life-saving drugs in India. Pharma distributors warn ...
Industry analysts and economists warn Trump's prescription drug policy is making it harder for smaller firms to compete while ...
The drug’s distributor, Viatris, said it was recalling one lot containing 51 bottles of 3 milligram extended release tablets.